A detailed history of Clearbridge Investments, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Clearbridge Investments, LLC holds 610,599 shares of PFE stock, worth $17.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
610,599
Previous 610,599 -0.0%
Holding current value
$17.8 Million
Previous $17.1 Million -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $564,838 - $661,885
-22,361 Reduced 3.53%
610,599 $17.1 Million
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $184 Million - $211 Million
-7,101,709 Reduced 91.82%
632,960 $17.6 Million
Q4 2023

Feb 09, 2024

SELL
$26.13 - $33.94 $48.4 Million - $62.8 Million
-1,850,411 Reduced 19.31%
7,734,669 $223 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $70.3 Million - $82.2 Million
-2,190,344 Reduced 18.6%
9,585,080 $318 Million
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $19 Million - $21.9 Million
-524,885 Reduced 4.27%
11,775,424 $432 Million
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $63.8 Million - $83.1 Million
-1,620,429 Reduced 11.64%
12,300,309 $502 Million
Q4 2022

Feb 10, 2023

SELL
$41.75 - $54.5 $16.5 Million - $21.5 Million
-395,037 Reduced 2.76%
13,920,738 $714 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $3.35 Million - $4.09 Million
-76,630 Reduced 0.53%
14,315,775 $626 Million
Q2 2022

Aug 11, 2022

BUY
$46.53 - $55.17 $96.4 Million - $114 Million
2,072,665 Added 16.82%
14,392,405 $755 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $6.92 Million - $8.58 Million
151,311 Added 1.24%
12,319,740 $638 Million
Q4 2021

Feb 11, 2022

SELL
$41.32 - $61.25 $1.36 Million - $2.01 Million
-32,873 Reduced 0.27%
12,168,429 $719 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $3.39 Million - $4.36 Million
86,436 Added 0.71%
12,201,302 $525 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $13.1 Million - $14.8 Million
-363,652 Reduced 2.91%
12,114,866 $474 Million
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $6.33 Million - $7.14 Million
-189,069 Reduced 1.49%
12,478,518 $452 Million
Q4 2020

Feb 10, 2021

SELL
$33.47 - $42.56 $59.9 Million - $76.2 Million
-1,789,922 Reduced 12.38%
12,667,587 $466 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $18.7 Million - $22 Million
-589,409 Reduced 3.92%
14,457,509 $531 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $7.33 Million - $8.89 Million
243,319 Added 1.64%
15,046,918 $492 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $54.4 Million - $77.7 Million
2,011,435 Added 15.72%
14,803,599 $483 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $1.23 Million - $1.4 Million
37,385 Added 0.29%
12,792,164 $501 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $10.1 Million - $13.1 Million
310,767 Added 2.5%
12,754,779 $458 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $3.69 Million - $4.15 Million
-99,887 Reduced 0.8%
12,444,012 $0
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $4.22 Million - $4.63 Million
-112,496 Reduced 0.89%
12,543,899 $533 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $26.9 Million - $30.6 Million
698,028 Added 5.84%
12,656,395 $552 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $25.5 Million - $31 Million
740,258 Added 6.6%
11,958,367 $527 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $6.17 Million - $6.57 Million
-186,968 Reduced 1.64%
11,218,109 $407 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $2.44 Million - $2.83 Million
-76,522 Reduced 0.67%
11,405,077 $405 Million
Q4 2017

Feb 14, 2018

SELL
$33.26 - $35.29 $1.86 Million - $1.97 Million
-55,837 Reduced 0.48%
11,481,599 $416 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $17 Million - $18.8 Million
549,544 Added 5.0%
11,537,436 $412 Million
Q2 2017

Aug 14, 2017

BUY
N/A
10,987,892
10,987,892 $369 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $163B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Clearbridge Investments, LLC Portfolio

Follow Clearbridge Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.